PATENT CLAIM ANALYSIS

Application Number: 16267590
Application Type: Utility
Filing Date: 2019-02
Publication Date: 2019-06
Patent Classification: ["514", "396000"]

Abstract:
The present invention is directed to: a) a method of treating telangiectasia; b) a method of treating inflammatory lesions; and c) a method of treating two or more symptoms of rosacea selected from erythema, telangiectasia, or inflammatory lesions comprising topical administration of a pharmaceutical composition comprising oxymetazoline and a pharmaceutically acceptable excipient.

Claim (Index 43):
The method of  claim 21 , wherein the pharmaceutical composition further comprises a pH regulator selected from the group consisting of sodium citrate dihydrate, anhydrous citric acid, and a combination thereof.

Metadata:
- Claim Count in Document: 98.0
- Percentile: 99.0
- Lexical Diversity: 1.60526
- Patent Class: 514.0
- Transitional Phrase Type: closed
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['13309403', '14737360', '15984918', '15429873', '14209927']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8319807307798828
- 35 USC 102 Novelty (BERT): 0.5946620019537628
- Combined Prediction Score: 0.8082488578972709
- Mean Citation Score: 397.863074
- Max Citation Score: 606.4654
- Similarity Product: 422.0380567614675

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test